Last edition
News about "Neurology Pharma"
Japan Patent Boosts Marvel's Neurology Pipeline for MB-204
Marvel Biosciences Corporation, through its subsidiary Marvel Biotechnology Inc., has secured a key intellectual property milestone after the Japan Patent Office granted a patent covering its lead therapeutic candidate, MB-204.
Neurology Pharma | 05/02/2026 | By Darshana | 133
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members